Detalhe da pesquisa
1.
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19.
Cell
; 183(1): 158-168.e14, 2020 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32979941
2.
Immunodeficiency syndromes differentially impact the functional profile of SARS-CoV-2-specific T cells elicited by mRNA vaccination.
Immunity
; 55(9): 1732-1746.e5, 2022 09 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35961317
3.
Dynamic MAIT Cell Recovery after Severe COVID-19 Is Transient with Signs of Heterogeneous Functional Anomalies.
J Immunol
; 212(3): 389-396, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38117799
4.
Functional SARS-CoV-2 cross-reactive CD4+ T cells established in early childhood decline with age.
Proc Natl Acad Sci U S A
; 120(12): e2220320120, 2023 03 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36917669
5.
Type I Interferon Autoantibodies Correlate With Cellular Immune Alterations in Severe COVID-19.
J Infect Dis
; 2024 Feb 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38421006
6.
Viral escape from NK-cell-mediated immunosurveillance: A lesson for cancer immunotherapy?
Eur J Immunol
; 53(11): e2350465, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37526136
7.
Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function.
Immunity
; 42(3): 443-56, 2015 Mar 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-25786176
8.
Expansions of adaptive-like NK cells with a tissue-resident phenotype in human lung and blood.
Proc Natl Acad Sci U S A
; 118(11)2021 03 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33836578
9.
Major alterations in the mononuclear phagocyte landscape associated with COVID-19 severity.
Proc Natl Acad Sci U S A
; 118(6)2021 02 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33479167
10.
High-dimensional profiling reveals phenotypic heterogeneity and disease-specific alterations of granulocytes in COVID-19.
Proc Natl Acad Sci U S A
; 118(40)2021 10 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34548411
11.
SARS-CoV-2 Antibodies in Commercial Immunoglobulin Products Show Markedly Reduced Cross-reactivities Against Omicron Variants.
J Clin Immunol
; 43(6): 1075-1082, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37058198
12.
COVID-19-specific metabolic imprint yields insights into multiorgan system perturbations.
Eur J Immunol
; 52(3): 503-510, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34837225
13.
Generation of NK cells with chimeric-switch receptors to overcome PD1-mediated inhibition in cancer immunotherapy.
Cancer Immunol Immunother
; 72(5): 1153-1167, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36355079
14.
Targeted plasma proteomics reveals signatures discriminating COVID-19 from sepsis with pneumonia.
Respir Res
; 24(1): 62, 2023 Feb 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36829233
15.
Challenges in αCD38-chimeric antigen receptor (CAR)-expressing natural killer (NK) cell-based immunotherapy in multiple myeloma: Harnessing the CD38dim phenotype of cytokine-stimulated NK cells as a strategy to prevent fratricide.
Cytotherapy
; 25(7): 763-772, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37055320
16.
Activation and Kinetics of Circulating T Follicular Helper Cells, Specific Plasmablast Response, and Development of Neutralizing Antibodies following Yellow Fever Virus Vaccination.
J Immunol
; 207(4): 1033-1043, 2021 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34321231
17.
MAIT cell compartment characteristics are associated with the immune response magnitude to the BNT162b2 mRNA anti-SARS-CoV-2 vaccine.
Mol Med
; 28(1): 54, 2022 05 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35562666
18.
NK cell frequencies, function and correlates to vaccine outcome in BNT162b2 mRNA anti-SARS-CoV-2 vaccinated healthy and immunocompromised individuals.
Mol Med
; 28(1): 20, 2022 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35135470
19.
Elevated CD21low B Cell Frequency Is a Marker of Poor Immunity to Pfizer-BioNTech BNT162b2 mRNA Vaccine Against SARS-CoV-2 in Patients with Common Variable Immunodeficiency.
J Clin Immunol
; 42(4): 716-727, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35290571
20.
Neutralizing SARS-CoV-2 Antibodies in Commercial Immunoglobulin Products Give Patients with X-Linked Agammaglobulinemia Limited Passive Immunity to the Omicron Variant.
J Clin Immunol
; 42(6): 1130-1136, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35538387